Opportunity Information: Apply for CDC RFA PS09 955
Apply for CDC RFA PS09 955
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Expansion of HIV/AIDS, STI and TB Laboratory Activities in the Namibia Institute of Pathology (NIP), Ltd. under the President s Emergency Plan for AIDS Relief" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 31, 2009 and posted on Mar 31, 2009.
- Applicants must submit their applications by May 28, 2009 Applications are due by 500pm Eastern time on closing date. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $12,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $2,144,093.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Namibia Institute of Pathology (NIP)
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity comes from the Centers for Disease Control and Prevention (CDC) under the President's Emergency Plan for AIDS Relief (PEPFAR) and focuses on strengthening laboratory capacity in Namibia through the Namibia Institute of Pathology (NIP), Ltd. The program is structured as a cooperative agreement, which typically means CDC would expect close collaboration with the recipient during implementation rather than simply issuing funds and stepping back. The overall intent is very public-health focused: improve national disease surveillance and expand the laboratory systems needed to diagnose, monitor, and manage HIV infection, sexually transmitted infections (STIs), and tuberculosis (TB), including conditions linked to HIV transmission and HIV-related illness.
The core purpose of the funding is twofold. First, it aims to improve Namibia's national surveillance for HIV, STIs, and TB. In practice, this implies better collection, testing, and reporting of laboratory data so that the country can track disease trends more accurately, detect outbreaks or shifts in transmission patterns earlier, and use evidence to guide prevention and treatment strategies. Second, it is designed to expand NIP's capacity to deliver laboratory services that support clinical care and public health decision-making. That includes strengthening diagnostic and monitoring services for HIV, STI, and TB patients and supporting the broader laboratory needs that arise in settings with high HIV burden, where co-infections and opportunistic diseases can be common.
Funding is intended to support approximately one award, with an anticipated award amount of about $2,144,093. The listed award floor is $1,000,000 and the award ceiling is $2,144,093, signaling that CDC expected a substantial, single-recipient effort rather than multiple smaller projects. The estimated total funding amount shown in the source data is $12,500,000, which may reflect broader funding context or multi-year planning, but the specific opportunity description emphasizes the roughly $2.144 million available for the anticipated single award under this announcement. There is no cost sharing or matching requirement, so the recipient would not be required to contribute a specified amount of non-federal resources to receive the award.
Eligibility is narrowly defined: the eligible applicant listed is the Namibia Institute of Pathology (NIP). In other words, this was not an open competition for a broad range of universities, NGOs, or laboratories; it was targeted to NIP based on the role the organization plays in Namibia's diagnostic and surveillance infrastructure. The funding activity category is Health, and the CFDA number provided is 93.067 (Global AIDS), tying the award directly to U.S. global HIV/AIDS programming.
Key administrative details place the opportunity in 2009. It was posted on March 31, 2009, with applications due by May 28, 2009, no later than 5:00 pm Eastern Time. The estimated funding date was stated as prior to September 30, 2009, consistent with U.S. federal fiscal year timing. The opportunity is archived as of June 27, 2009, which generally indicates the application window has closed and the listing is retained for recordkeeping and reference.
For applicants or stakeholders who needed the full announcement, CDC directed users to Grants.gov and provided a contact point through the Procurement and Grants Office (PGO TIMS) at 770-488-2700 with a general email contact. Overall, the announcement describes a targeted investment meant to strengthen Namibia's laboratory backbone for HIV, STI, and TB surveillance and patient management, leveraging NIP as the central implementing institution in alignment with PEPFAR public health goals.
Frequently Asked Questions (FAQs)
1) What is this grant opportunity about?
This opportunity from the Centers for Disease Control and Prevention (CDC) under the President's Emergency Plan for AIDS Relief (PEPFAR) focuses on strengthening laboratory capacity in Namibia through the Namibia Institute of Pathology (NIP), Ltd. The intent is to improve laboratory systems that support public health surveillance and clinical care related to HIV, sexually transmitted infections (STIs), and tuberculosis (TB).
2) Who is the funding agency and program behind this opportunity?
The funding agency is the CDC. The opportunity is aligned with PEPFAR and is associated with the Global AIDS program (CFDA 93.067).
3) What type of award is this?
The program is structured as a cooperative agreement. This typically means CDC expects close collaboration with the recipient during implementation rather than simply providing funds with minimal involvement.
4) What are the main goals of the funding?
The core purpose is twofold: (1) improve Namibia's national surveillance for HIV, STIs, and TB, and (2) expand NIP's capacity to deliver laboratory services that support clinical care and public health decision-making for HIV, STI, and TB patients, including conditions linked to HIV transmission and HIV-related illness.
5) What does "improving national surveillance" mean in practical terms for this opportunity?
Based on the description, it implies strengthening the collection, testing, and reporting of laboratory data so Namibia can track disease trends more accurately, detect outbreaks or changes in transmission patterns earlier, and use evidence to guide prevention and treatment strategies.
6) What laboratory areas or diseases does the grant emphasize?
The opportunity emphasizes laboratory systems and services connected to HIV infection, sexually transmitted infections (STIs), and tuberculosis (TB), including conditions linked to HIV transmission and HIV-related illness, particularly in high HIV burden settings where co-infections and opportunistic diseases may be common.
7) Who is eligible to apply?
Eligibility is narrowly defined. The only eligible applicant listed is the Namibia Institute of Pathology (NIP), Ltd. This was not described as an open competition for a broad range of organizations.
8) How many awards did CDC expect to make?
CDC anticipated approximately one award, indicating the effort was designed as a substantial, single-recipient investment rather than multiple smaller awards.
9) How much funding is available for this opportunity?
The anticipated award amount is about $2,144,093. The award floor is $1,000,000 and the award ceiling is $2,144,093.
10) What is the estimated total funding amount of $12,500,000 referenced in the source data?
The opportunity notes an estimated total funding amount of $12,500,000, which may reflect broader funding context or multi-year planning. However, the specific opportunity description emphasizes roughly $2.144 million for the anticipated single award under this announcement.
11) Is there a cost sharing or matching requirement?
No. The opportunity states there is no cost sharing or matching requirement, so the recipient is not required to contribute a specified amount of non-federal resources as a condition of receiving the award.
12) What is the funding activity/category?
The funding activity category listed is Health.
13) What is the CFDA number for this program?
The CFDA number provided is 93.067 (Global AIDS).
14) When was the opportunity posted?
The opportunity was posted on March 31, 2009.
15) What was the application deadline?
Applications were due by May 28, 2009, no later than 5:00 pm Eastern Time.
16) When was the award expected to be made?
The estimated funding date was stated as prior to September 30, 2009.
17) What does it mean that the opportunity is archived?
The opportunity is archived as of June 27, 2009. This generally indicates the application window has closed and the listing is retained for recordkeeping and reference.
18) Where could applicants or stakeholders find the full announcement?
CDC directed users to Grants.gov for the full announcement.
19) Who was the contact listed for questions?
The contact point provided was the CDC Procurement and Grants Office (PGO TIMS) at 770-488-2700, with a general email contact also referenced.
20) Why was this opportunity targeted specifically to NIP?
The description indicates it was targeted to NIP based on the role NIP plays in Namibia's diagnostic and surveillance infrastructure, positioning NIP as the central implementing institution for strengthening national laboratory capacity.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Increasing Public Health Workforce Capacity to Implement and Deliver Laboratory Services and Public Health Interventions in the Dominican Republic under the President s Emergency Plan for AIDS Relief
Previous opportunity: Implementation and Strengthening of Laboratory Health Systems in PEPFAR Countries through Quality Management Systems and Laboratory Accreditation under the President s Emergency Plan for AIDS Relief
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS09 955
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS09 955) also looked into and applied for these:
| Funding Opportunity |
|---|
| Increasing Public Health Workforce Capacity to Implement and Deliver Laboratory Services and Public Health Interventions in the Dominican Republic under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 959 Funding Number: CDC RFA PS09 959 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Supporting the Implementation and Expansion of High Quality HIV Prevention, Care and Treatment Activities at Facility and Community Level in the Republic of Kenya under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 962 Funding Number: CDC RFA PS09 962 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $275,000,000 |
| Strengthening HIV/AIDS, STI and TB Prevention, Care and Treatment Activities within the Addis Ababa University Community, Ministry of Health (MoH) and Selected Regions in Ethiopia under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 9101 Funding Number: CDC RFA PS09 9101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $367,688 |
| Prevention in Rural and Urban Hotspots for Most at Risk Populations (MARPs) including Students, Mobile Merchants, Commercial Sex Workers, and Daily Laborers in Amhara Region of the Federal Democratic Republic of Ethiopia under the President s Emergen Apply for CDC RFA PS09 9102 Funding Number: CDC RFA PS09 9102 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Rapid Scale Up of HIV/AIDS Care and Treatment Services in the Kingdom of Swaziland under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 913 Funding Number: CDC RFA PS09 913 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Achievement and Maintenance of Universal Coverage with Long Lasting Insecticide Treated Apply for USAID TANZANIA 09 002 RFA Funding Number: USAID TANZANIA 09 002 RFA Agency: Tanzania USAID Dar es Salaam Category: Health Funding Amount: $40,000,000 |
| Capacity Building Assistance to Support Sustainable HIV/AIDS Integrated Laboratory Program Development under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 914 Funding Number: CDC RFA PS09 914 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $15,000,000 |
| Strengthening the State of Tamil Nadu Response to HIV/AIDS in Chennai, India through the Tamil Nadu State AIDS Control Society (TNSACS) under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 918 Funding Number: CDC RFA PS09 918 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| Improving Diagnosis and Preventing the Spread of Tuberculosis in HIV/AIDS Infected People in the Kingdom of Cambodia under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 919 Funding Number: CDC RFA PS09 919 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Expansion of HIV Prevention Counseling, Psychosocial Support and Outreach Services in Botswana under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 926 Funding Number: CDC RFA PS09 926 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,825,000 |
| Technical Assistance for Injection Safety in the Republic of Botswana under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 927 Funding Number: CDC RFA PS09 927 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Expansion of Safe Male Circumcision Services to Prevent HIV in Botswana under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 928 Funding Number: CDC RFA PS09 928 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,953,063 |
| Pediatric ART, HIV and TB/HIV Care and Outreach Support in the Republic of Botswana under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 929 Funding Number: CDC RFA PS09 929 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $853,000 |
| Strengthening TB/HIV Collaboration in the Kingdom of Lesotho under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 930 Funding Number: CDC RFA PS09 930 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,750,000 |
| Capacity Building Assistance for Global HIV/AIDS Microbiological Laboratory Program Development through Technical Assistance Collaboration under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 932 Funding Number: CDC RFA PS09 932 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Developing Advanced Prevention, Health Systems and Strategic Information Systems in the Socialist Republic of Vietnam under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 9107 Funding Number: CDC RFA PS09 9107 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $315,000 |
| Strengthening Laboratory Systems and Building Sustainable Human Capacity in the Socialist Republic of Vietnam under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 9108 Funding Number: CDC RFA PS09 9108 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $320,000 |
| Provision of Technical Assistance to Strengthen HIV Strategic Information Activities and Monitoring and Evaluation Systems for PEPFAR Implementing Partners in the Republic of Uganda under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 9110 Funding Number: CDC RFA PS09 9110 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,230,000 |
| Strengthening Basic Prevention of Mother to Child Transmission (PMTCT) in the Republic of Cameroon under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 9109 Funding Number: CDC RFA PS09 9109 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Strengthening the Blood Transfusion Services in the Republic of Rwanda under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 9112 Funding Number: CDC RFA PS09 9112 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS09 955", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.